on ovarian weight increase in mice treated with human chorionic gonadotrophin-the so-called 'ovarian augmentation test.' This technique is precise, specific and sufficiently sensitive to measure the small amounts of the hormone present in human body fluids. A large number of methods for the quantitative determination of LH are available including those depending on ventral prostatic weight and ovarian ascorbic acid and cholesterol depletion in rats; none of these procedures is suitable for routine clinical use. The mouse uterus test, which measures a mixture of FSH and LH activities, has been widely employed in patients and provides a a satisfactory index of anterior pituitary activity in health and disease. Its use by clinical biochemists is to be recommended provided a satisfactory animal colony is available.
For the estimation of HGH in plasma the method of choice at present is the radio-immuno-7 logical procedure of Hunter and Greenwood (1964) . This technique is considerably more sensitive than previously described biological procedures and once it has been established a large number of determinations can be made simultaneously. The main disadvantage of the method from the point of view of the clinical biochemist is the high initial cost of the equipment required.
For ACTH and TSH none of the methods at present available are suitable for routine clinical use. It is to be hoped that in the future satisfactory radio-immunological assays will be developed which will widen the sphere of applicability of estimations of these hormones. At the present time gonadotrophin assays are generally conducted in urine rather than in blood and all results should be expressed in terms of a standard preparation. In the majority of studies reported in the literature specific assay methods for follicle-stimulating (FSH) and luteinising hormones (LH) have not been employed. Most of the results have been obtained by the test depending on the enlargement of the uterus in the intact immature mouse. This procedure is thought not to be specific for either FSH or LH and is claimed to measure 'total gonadotrophic activity.'
Using the mouse uterus test normal levels of human pituitary gonadotrophins (HPG) in urine have been established for adult males, women during reproductive life and postmenopausal women. In children, levels are often too low to be detected. Excretion patterns of FSH and LH have been found to vary considerably between individual subjects when assays are conducted during the normal menstrual cycle. If the mouse uterus test is employed high levels of urinary HPG are sometimes but not always found at mid-cycle.
Gonadotrophin assays in urine have been conducted in a wide variety of clinical states. In many of these such estimations have proved to be of little or no diagnostic or prognostic value. At present HPG assays are useful in the diagnosis of pituitary, ovarian or testicular failure with particular reference to patients suffering from primary or secondary amenorrhea. Little or no data are available on FSH and LH levels in these conditions. Gonadotrophin assays by the mouse uterus test have also proved to be of value in assessing the effectiveness of ovarian irradiation and the completeness of hypophysectomy.
The Assessment of ACTH Production J. G. SPRUNT
DUNDEE
The measurement of plasma ACTH is the most direct method of assessing ACTH production, but until now this has meant bioassay, which is expensive and time consuming. Using the bioassay, Ney et al, (1963) has established that plasma ACTH levels are about 0'1 to 0·59 mU/IOOmi. Raised levels are found in Cushing's syndrome following bilateral adrenalectomy and in Addison's disease. The high levels persist in the former disease despite normal replacement therapy, whereas they tend to return to near normal levels in treated Addison's disease. Higher levels of circulating corticosteroids are required to suppress the secretion of ACTH by the pituitary in Cushing's syndrome, and this is the basis of the dexamethasone suppression test. Patients with Cushing's syndrome tend to have higher basal levels of plasma ACTH, but this is accentuated by the absence of the normal diurnal variation of ACTH production. This is reflected in the loss of the diurnal variation of plasma cortisol.
The pituitary reserve of ACTH can be assessed using the metyrapone test. The results of this test have to be interpreted carefully, because a 8 diminished response can also occur if (1) the plasma cortisol does not fall on administering the drug. This could be due to too small a dose, inadequate absorption, too rapid metabolism (as perhaps in hyperthyroidism), or antagonism of metyrapone (e.g. by eestrogens), (2) the hypothalamus may not detect the fall in plasma cortisol due to hypothalamic dysfunction (e.g. 'pituitary' dwarf). Phenothiazines and phenytoin may inhibit the hypothalamo-pituitary axis and (3) there can be no response if the adrenal gland is non-functioning. The radio-immunoassay of Hunter and Green-hours fasting. Secretion is abolished by glucose wood has been used to measure human pituitary but 3 hours after glucose a 'secondary rise' in growth hormone (HGH) in the plasma of normal HGH, whose magnitude is proportional to the adults and children, patients suffering from glucose load, occurs. Acromegaly is characterised acromegaly and dwarfed children. The pattern of by consistently raised levels which do not fall secretion in normal adults is wholly consistent after glucose. In children glucose abolishes HGH with the concept that HGH has a major role secretion and the secondary rise tends to reach (through its lipotrophic action) in initiating and higher levels. However, the principal distinction maintaining the mobilisation of depot fat. Thus, between children and adults is that the former HGH is low « I umg.jml.) in the resting post-show much higher values during the night. Very absorptive state. 20--70 fold increases occur few small children are unable to secrete growth after 1 hours walking at 4 m.p.h. This rise does hormone, and this can be shown by estimating not occur if sugar is taken during the walk. In HGH in three samples taken at hourly intervals the resting state growth hormone begins to after an overnight fast. appear in the blood (> 1 umg.jrnl.) after 18 The injection of intravenous insulin carried vasopressin, a polypeptide with a corticotrophinout with adequate safeguards under standardised releasing action, is also of value as a pituitary conditions yields valuable information regarding function test. Used in conjunction with the hypothalamic and pituitary function when plasma insulin test it enables pituitary disorders to be levels of sugar, cortisol and growth hormone are differentiated from those involving the hypodetermined. The use of a test based on the plasma thalamus. cortisol response to the infusion of lysine-(A full version of this paper is in the press. Ed.)
